Results

Total Results: 900 records

Showing results for "author year description".

101. Disposition of Comments Report for Stroke Prevention in Atrial Fibrillation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_disposition-comments.pdf
     August 23, 2013 - for non-inferiority; 1.7% per year vs. 2.2% per year for rivaroxaban and warfarin, respectively; HR … Excellent description of results. … Rates were: 0.26% per year for rivaroxaban vs. 0.44% per year for warfarin. … Rates were: 0.04% per year for rivaroxaban vs. 0.19% per year for warfarin. … Rates were: 1.53% per year for rivaroxaban vs. 1.71% per year for warfarin.

102. Disposition of Comments Report for Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
     January 27, 2014 - Characteristics” for Key Question 1, we report that “the median age of patients was between 60 and 70 year … Peer Reviewer#1 Introduction The description needs to be clarified regarding the clinical indications … Peer Reviewer#1 Methods There is no description of whether or not the authors included grey literature … An explanation of how pain was evaluated is included in each study description. … than compression alone, especially for ulcers that had failed therapy and were present for over 1 year

103. Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol.pdf
     October 15, 2024 - cycle length, with elevated but variable follicle-stimulating hormone (FSH, >25 IU/L), and through 1 year … menopause, premature menopause, early menopause • Early perimenopausal women (prior to and through 1 year … menopause, premature menopause, early menopause • Early perimenopausal women (prior to and through 1 year … Any protocol amendments will be listed in this section with the date of the amendment, a description … or therap*)).ti,bt,ab,kf. 155871 29 Structure # Searches Results Description 59 (

104. Disposition of Comments for CER 175 Total Worker Health (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/worker-health_disposition-comments.pdf
     May 31, 2016 - Unfortunately, companies don't care about studies of less than one year. … that the duration of included studies is a limitation; very few studies measured outcomes beyond one year … We agree that a descriptive paper focused on the pre-post interventions (including a description of … Seems like a missed opportunity for those 5-year trials. … Distinguishing between these possibilities from a program description in the literature may be challenging

105. Disposition of Comments Report for Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_disposition-comments.pdf
     September 10, 2014 - Introduction Same point again about the “large proportion” of women undergoing biopsy over a 10 year … Executive Summary Actually, the 10 year false positive biopsy rate is 7% for annual screening and … a more detailed description in the Main Report text. … a more detailed description in the Main Report text. … If one year f/u results in the loss of many studies this could be relaxed; but including studies with

106. Monitoring-Programs-Rapid-Research-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research-appendix-c.xlsx
     May 31, 2025 - Detailed Information for Contextual Questions 1, 2, and 3 Studies Author, Year Publication Description … Country Setting(s) Purpose Targeted Supply/Disruption Type of Monitoring System Description of Monitoring

107. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
     January 01, 2007 - Only about 5% of SCD cases survive.4 SCD results in 300,000-456,000 deaths per year, or about 12-19% … SCD is 1.8 per 1000 in the general US population,9 which mirrors the rate of about 2 per 1000 per year … SCD/VA ICD-9 diagnosis codes ICD-9 Code Description 427.1 Paroxysmal Ventricular Tachycardia; Ventricular

108. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
     January 01, 2005 - Only about 5% of SCD cases survive.4 SCD results in 300,000-456,000 deaths per year, or about 12-19% … SCD is 1.8 per 1000 in the general US population,9 which mirrors the rate of about 2 per 1000 per year … SCD/VA ICD-9 diagnosis codes ICD-9 Code Description 427.1 Paroxysmal Ventricular Tachycardia; Ventricular

109. Dispostion of Comments Report for Child and Adolescent Exposure to Trauma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_disposition-comments.pdf
     February 11, 2013 - We have added some description about the main findings of the child maltreatment complementary report … subject to terrorist attacks over a number of years prior to the intervention or to the Tsunami over a year … N/A Peer Reviewer #2 Methods Concise description of evidence grading is given N/A TEP #5 Methods … authors explain that differentiation of theoretical orientation is limited because in many studies, the description … Excluded for “wrong publication type” (e.g., Appendix C) – I may have missed it, but I didn’t see description

110. Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
     March 07, 2012 - Clearly newborns barely make immunoglobulin whereas 18 year olds have adult levels. … None of the studies looked specifically at children with joint swelling; we added this to the description … We have reworded the outcome description for KQ5. … Outcome of high titer ANA positivity in individuals w/o connective tissue disease: 10 year followup … Outcome of high titer ANA positivity in individuals w/o connective tissue disease: 10 year followup

111. Disposition of Comments Report for Outpatient Case Management for Adults With Medical Illness and Complex Care Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_disposition-comments.pdf
     January 01, 2013 - TEP #1 General Comments Population of Interest (Page ES-4) is another section where a description … Text has been added to clarify that this description of case management is based on studies reviewed … However, the summary does not explicitly state if this description was developed based on the research … implementation, evaluation and interaction." in addition, the definitions should be listed alphabetically by author … We have added the ANCC definition and reorganized the listing of definitions by author.

112. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pain-chronic_disposition-comments.pdf
     September 01, 2011 - For example, the first subsection is titled “Description of Technology and Context for Use.” … Peer Reviewer #5 Findings This reviewer finds it odd that the description of the technology and context … In the description of availability, a discussion of temporal trends could strengthen the point made … good data on the reasons for decline; some indicators are provided in the Findings section, under Description … A description of the qualitative research methodology employed, including how the interviewees were

113. Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
     October 12, 2016 - Perhaps a brief description of the methodology to quantitate omega-3 levels for the included studies … have added it to the description of the findings of this study. … Author name “van Goor”-this study is presented in the tables twice, pg 132 & pg 133-134 Pg 170 line … We have made every effort to be transparent in our description of our methods and decisions. … Customarily, update searches commence with the publication year one year prior to the latest search

114. CER 221 Disposition of Comments: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
     October 11, 2019 - The current qualitative description is sufficient according to our clinical experts and other peer … Risk trajectories of readmission and death in the first year after hospitalization for chronic obstructive … Descriptions were presented at the end of study description for each KQ, pages 13, 22, 42, 45. … Peer reviewer #4 Results Page 42/302: Current description of the Evidence Base is superficial and does … This comment applies to the description of evidence base for all key questions.

115. Disposition of Comments for Strategies To Prevent Weight Gain Among Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_disposition-comments.pdf
     March 25, 2013 - We recommended the difference in groups to be at least 1 cm for year 1, 2 cm for year 2, etc. … Peer Reviewer 1 Results Table 14 – Primary Aim is missing as is description of “Group 1” Study … Commentator & Affiliation Section Comment Response Peer Reviewer 1 Results Table 15 – based on the description … We recommended the difference in groups to be at least 1 cm for year 1, 2 cm for year 2, etc. … We recommended the difference in groups to be at least 1 cm for year 1, 2 cm for year 2, etc.

116. Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
     August 16, 2016 - We have clarified the description of grading strength of evidence. … The description has been modified. TEP Reviewer #5 Introduction P 3. … We also added to the description of the RCTs and the discussion. … The description has been modified. … We have added this description to CORAL and included the limitation in that section of the Discussion

117. Disposition of Comments_Technical Brief No. 43: Measuring Healthcare Organization Characteristics in Cancer Care Delivery Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/organization-cancer-care-disposition-comments.pdf
     June 20, 2023 - organization-cancer-care/tech-brief Published Online: June 20, 2023 2 Peer Reviewer Comments and Author … We appreciated your description of the frameworks and have incorporated that text, as well. 23 … The author list has now been added to the front matter, which will hopefully clarify this point. … This a clear and comprehensive description of the problem, the process, and the findings. … Characteristics in Cancer Care Delivery Research Comments to Draft Report Peer Reviewer Comments and Author

118. Disposition of Comments for Treatment of Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
     April 01, 2012 - This should be done using Corporate Author and keyword searches. … The Corporate Author search alone is not reliable. … Three-year follow-up of the tube versus trabeculectomy study. … Also, as the author points out, there is no formal economic analysis comparing trabeculectomy, laser … A description of the studies included precedes this paragraph, but there is no description or metaanalysis

119. Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol-final.pdf
     October 15, 2024 - cycle length, with elevated but variable follicle-stimulating hormone (FSH, >25 IU/L), and through 1 year … menopause, premature menopause, early menopause • Early perimenopausal women (prior to and through 1 year … menopause, premature menopause, early menopause • Early perimenopausal women (prior to and through 1 year … ti,bt,kf. 37578 29 Structure # Searches Results Description 56 ("use" adj3 (medication … or therap*)).ti,bt,ab,kf. 155871 30 Structure # Searches Results Description 59 (

120. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
     February 01, 2012 - We added a description of myxedema coma Source: http://www.effectivehealthcare.ahrq.gov/index.cfm … UPdate...nearly 1 year old). … Introduction p. 14, line 43--on the third review, state number and type of studies We have added this description … As noted above, these two studies are problematic and there is no evidence to support a 1-2 year observation … We removed the “1-2 year” from the sentence Peer Reviewer #6 Results Table 10AB is great, except